Regeneron Pharmaceuticals Inc.

REGN NMS
Pharmaceuticals
Tarrytown, NY
2016 Revenue (US$ Millions)$4,860
Revenue Growth (%)18.44%
2015 Revenue (US$ Millions)$4,104
Net Income (US$ Millions)$896
Common Shares Outstanding (Millions)106.01
Earnings Per Share (US$)$7.70
Price to Earnings Ratio63.49
Total Equity (US$ Millions)$4,449
Return on Equity (%)24.50%
Long Term Debt (US$ Millions)$352
Debt to Equity Ratio (%)0.08%
Market Capitalization (US$ Millions)$38,915
Total Assets (US$ Millions)$6,973
Current Assets (US$ Millions)$3,180
Inventories (US$ Millions)$399
Current Liabilities (US$ Millions)$1,241
Cost Of Goods Sold (US$ Millions)$300
Asset Turnover0.77
Inventory Turnover0.94